Market Overview:The global Conjugate Vaccine Market is estimated to be valued at US$ 18,012.08 million in 2022 and is expected to exhibit a CAGR of 9.6% over the forecast period of 2022-2030, as highlighted in a new report published by Coherent Market Insights. Conjugate vaccines are a groundbreaking advancement in the field of immunization, as they combine bacterial or viral antigens with...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian